Notably, GAS6-AS1 overexpression promoted subcutaneous xenograft tumor growth (Fig. 3A), whereas GAS6-AS1 knockdown significantly reduced tumor volume (Fig. 3B). The gene discussed is GAS6; the disease is neoplasm.